The global companion diagnostics
(CDx) market was valued at US$ 1,614.5 million in 2015 and is projected to
expand at a CAGR of 12.0% during the forecast period 2016 to 2024
Companion
diagnostic (CDx) is a diagnostic tool used to determine the suitability of
a drug therapy to the patient. It has become a critical part of targeted cancer
therapy that allows for development of personalized therapy can be developed
and administered to the patient. Whole blood samples, tissues samples, or
buccal samples are collected and tested for diagnosis and identification of
targeted disease biomarker. CDx is usually utilized in identifying genetic
mutations and the health and treatment approach implications. In July 2016, the
U.S. FDA released a draft guideline for development of a therapeutic product
accompanying an IVD companion diagnostic. Companion diagnostics include Gleevec
(imatinib mesylate) and BCR-ABL LDT and DAKO C-KIT PharmDx, Herceptin (trastuzumab)
and DAKO Herceptest; and Nolvaldex (tamoxifen) and laboratory-developed
estrogen receptor positive test.
To Get Sample Copy of
Report visit @ https://marketreportscenter.com/request-sample/508244
Market Dynamics:
Companion
diagnostics are beneficial for pharmaceutical companies who face challenges
with respect to high drug development cost, safety and outcome of clinical
trials, and long product approval time. Companion diagnostics lowers
development costs, improves time to market and enhances drug safety by enabling
rapid identification of target biomarker and the most effective drug therapy.
For patients, the technology provides better treatment outcomes and lower
morbidity risk. Use of technologies such as PCR, immunohistochemistry, and gene
sequencing has enabled accurate diagnosis and determination of targeted cancer
therapy. As the CDx tests also aid in revealing the off-target effects of a
drug along with identification of a molecular target, CDx have become and
indispensable tool for oncologists.
Market Taxonomy:
This
report segments the global companion diagnostics market on the basis of
application, technology, and geography. On the basis of application, the market
is categorized into breast cancer, lung cancer, colorectal cancer, gastric
cancer, melanoma, and others. On the basis of technology, the market is
segmented into immunohistochemistry, real-time PCR, gene sequencing,
Fluorescence in situ hybridization (FISH), and others. For comprehensive
understanding of market dynamics, the global companion diagnostics market is
analyzed across key geographical regions namely North America, Europe, Asia
Pacific, Latin America, Africa, and Middle East. Each of these regions is
analyzed on basis of market findings across major countries in these regions
for a macro-level understanding of the market.
Get the Exemplified
Analysis for the Products of Companion diagnostic (CDx) @ https://marketreportscenter.com/reports/508244/companion-diagnostics-market-global-industry-trends-analysis-and-forecast-2017-2024
Key features of the study:
•
This report provides in-depth analysis of the companion diagnostics and
provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%))
for the forecast period: 2016 to 2024, considering 2015 as the base year
•
It elucidates potential revenue opportunity across different segments and
explains attractive investment proposition matrix for this market
•
This study also provides key insights about market drivers, restraints,
opportunities, new product launches or approval, regional outlook, and competitive
strategy adopted by the leading players
•
It profiles leading players in the global companion diagnostics market based on
the following parameters company overview, financial performance, product
portfolio, geographical presence, distribution strategies, key developments and
strategies and future plans
•
Key companies covered as a part of this study include Abbott Laboratories,
Inc., Agilent Technologies, Inc., Danaher Corporation, GE Healthcare, Qiagen
N.V., Roche Diagnostics, Myriad Genetics, Inc., bioMérieux SA, Illumina, Inc.
and Siemens Healthcare
•
Insights from this report would allow marketers and management authorities of
companies to make informed decision with respect to their future product
launch, technology upgrades, market expansion, and marketing tactics
•
The global companion diagnostics market report caters to various stakeholders
in this industry, including investors, device manufacturers, distributors and
suppliers for companion diagnostics, research and consulting firms, new entrants,
and financial analysts
•
Various strategy matrices used in analyzing the companion diagnostics market
would provide stakeholders vital inputs to make strategic decisions accordingly.
Ask for Discount @
https://marketreportscenter.com/request-discount/508244
About Us:
Market
Reports Center is an e-commerce platform obliging the needs of knowledge
workers, experts, professionals who are subject to market research information
for their work, or to make strategic business decisions. Market Reports
Center’s team consistently works to update and extend our existing repository
of market research reports by partnering with new publishers and adding their
studies to our website.
Media Contact:
Sam
Collins
Market
Reports Center
Phone
No: 1-646-883-3044 (US)
Email: info@marketreportscenter.com
Website: https://www.marketreportscenter.com/
No comments:
Post a Comment